Kurt Neeser is Senior Director at Analytica Laser, Certara’s Evidence and Access Group in Germany, where he manages HEOR related projects. His focus is on health economic evaluations, systematic and targeted literature reviews, and Health Technology Assessments (HTA) including the systematic assessment of the methodological study quality.
Kurt works since 1996 as consultant for medical and pharmaceutical companies. During his career he has successfully managed numerous projects in various indications as metabolic disorders, cardiology, oncology, neurology, and mental disorders. Kurt has comprehensive experience in developing and implementing health economic concepts for drugs and medical devices and has effectively published numerous articles in peer-reviewed journals and on scientific congresses. Further, he trains interns and supervises their bachelor theses.
Prior to joining Analytica Laser in 2011, he was working during 9 years for the Institute for Medical Informatics and Biostatistics (IMIB), a subsidiary of Roche Diagnostics, as project manager and head of health economics.
Kurt has a PhD in veterinary medicine and a Master in Public Health. A mammography-screening model developed by him was awarded by the Swiss Society of Radiology.